| Authors: |
Anadón C; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Guil S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Simó-Riudalbas L; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Moutinho C; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Setien F; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Martínez-Cardús A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Moran S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Villanueva A; Translational Research Laboratory, IDIBELL-Institut Catala d'Oncologia, Barcelona, Catalonia, Spain., Calaf M; Translational Research Laboratory, IDIBELL-Institut Catala d'Oncologia, Barcelona, Catalonia, Spain., Vidal A; Department of Pathological Anatomy, Bellvitge Unviversity Hospital, Barcelona, Catalonia, Spain., Lazo PA; Experimental Therapeutics and Translational Oncology Program, Instituto de Biologıa Molecular y Celular del Cancer, CSIC-Universidad de Salamanca, Salamanca, Spain.; Instituto de Investigacion Biomedica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain., Zondervan I; MRC-Holland, Amsterdam, The Netherlands., Savola S; MRC-Holland, Amsterdam, The Netherlands., Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Yokota J; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Genomics and Epigenomics of Cancer Prediction Program, Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Catalonia, Spain., Ribas de Pouplana L; Institute for Research in Biomedicine (IRB), c/ Baldiri Reixac 10 08028, Barcelona, Catalonia, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain., Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.; Institute for Research in Biomedicine (IRB), c/ Baldiri Reixac 10 08028, Barcelona, Catalonia, Spain.; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain. |
